These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8935222)

  • 21. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects.
    Agrawal AR; Tandon M; Sharma PL
    Int J Clin Pract; 2007 Nov; 61(11):1812-8. PubMed ID: 17935545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Brunner D
    Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of lovastatin in diabetic patients treated with chlorpropamide.
    Johnson BF; LaBelle P; Wilson J; Allan J; Zupkis RV; Ronca PD
    Clin Pharmacol Ther; 1990 Oct; 48(4):467-72. PubMed ID: 2225707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxypropylmethylcellulose lowers cholesterol in statin-treated men and women with primary hypercholesterolemia.
    Maki KC; Carson ML; Miller MP; Anderson WH; Turowski M; Reeves MS; Kaden V; Dicklin MR
    Eur J Clin Nutr; 2009 Aug; 63(8):1001-7. PubMed ID: 19209184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of effect of simvastatin on insulin sensitivity in Type 2 diabetic patients with hypercholesterolaemia: results from a double-blind, randomized, placebo-controlled crossover study.
    Hwu CM; Kwok CF; Chen HS; Shih KC; Lee SH; Hsiao LC; Lin SH; Ho LT
    Diabet Med; 1999 Sep; 16(9):749-54. PubMed ID: 10510951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of folate supplementation on serum homocysteine and plasma total antioxidant capacity in hypercholesterolemic adults under lovastatin treatment: a double-blind randomized controlled clinical trial.
    Shidfar F; Homayounfar R; Fereshtehnejad SM; Kalani A
    Arch Med Res; 2009 Jul; 40(5):380-6. PubMed ID: 19766902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
    Saltissi D; Morgan C; Rigby RJ; Westhuyzen J
    Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N; Ramires JA
    Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of pravastatin on serum adiponectin levels in female patients with type 2 diabetes mellitus.
    Kim JH; Lee MR; Shin JA; Lee SS; Lee JM; You SJ; Yoon KH; Chang SA
    Atherosclerosis; 2013 Apr; 227(2):355-9. PubMed ID: 23466100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
    Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antilipemic effectiveness of pentaerythritol tetranicotinate on hyperlipidemic patients with or without diabetes mellitus--a double-blind, randomized and two-period change-over experiment.
    Ho LT; Chern JC; Hsu SC; Chen RL; Kwok CF; Wu MS; Chen JJ; Jap TS
    Proc Natl Sci Counc Repub China B; 1985 Jan; 9(1):20-9. PubMed ID: 3916369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of lovastatin on plasma lipid, plasma glucose and insulin metabolism of patients with type II B hyperlipemia].
    Chen X; Huang D; Huang M; Zhang H; Xie M; Yu Y; Hu P
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):444-5, 454. PubMed ID: 11387965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of lovastatin on serum lipid profile in the treatment of dyslipoproteinaemia in uraemic patients on continuous ambulatory peritoneal dialysis.
    Li PK; Mak TW; Chiu K; Mak GY; Leung CB; Lui SF; Lam CW; Lai KN
    Aust N Z J Med; 1993 Jun; 23(3):252-7. PubMed ID: 8352699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simvastatin reduces plasma lipid levels and improves insulin action in elderly, non-insulin dependent diabetics.
    Paolisso G; Sgambato S; De Riu S; Gambardella A; Verza M; Varricchio M; D'Onofrio F
    Eur J Clin Pharmacol; 1991; 40(1):27-31. PubMed ID: 2060542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients.
    Buxbaum JD; Cullen EI; Friedhoff LT
    Front Biosci; 2002 Apr; 7():a50-9. PubMed ID: 11900994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combined effects of novel tocotrienols and lovastatin on lipid metabolism in chickens.
    Qureshi AA; Peterson DM
    Atherosclerosis; 2001 May; 156(1):39-47. PubMed ID: 11368995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase.
    Tobert JA; Hitzenberger G; Kukovetz WR; Holmes IB; Jones KH
    Atherosclerosis; 1982 Jan; 41(1):61-5. PubMed ID: 6918220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lovastatin does not affect oral glucose tolerance in hypercholesterolemic patients.
    McCrea JB; Fruncillo RJ; Holland SD; Conroy JA; Shingo S; Spector R; Bjornsson TD
    J Clin Pharmacol; 1993 Jun; 33(6):581-5. PubMed ID: 8366184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma apolipoprotein E, high density lipoprotein1 (HDL1) and urinary mevalonate excretion in pancreatectomized diabetic dogs: effects of insulin and lovastatin.
    Gleeson JM; Hejazi JS; Kwong L; Chan IF; Le T; Alberts AW; Wilson DE
    Atherosclerosis; 1990 Sep; 84(1):1-12. PubMed ID: 2248616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.